Till sidans topp

Sidansvarig: Webbredaktion
Sidan uppdaterades: 2012-09-11 15:12

Tipsa en vän
Utskriftsversion

Agmatine attenuates the d… - Göteborgs universitet Till startsida
Webbkarta
Till innehåll Läs mer om hur kakor används på gu.se

Agmatine attenuates the disruptive effects of phencyclidine on prepulse inhibition.

Artikel i vetenskaplig tidskrift
Författare Erik Pålsson
Kim Fejgin
Caroline Wass
Daniel Klamer
Publicerad i European journal of pharmacology
Volym 590
Nummer/häfte 1-3
Sidor 212-6
ISSN 0014-2999
Publiceringsår 2008
Publicerad vid Institutionen för neurovetenskap och fysiologi, sektionen för farmakologi
Sidor 212-6
Språk en
Länkar dx.doi.org/10.1016/j.ejphar.2008.06...
Ämnesord Agmatine, pharmacology, Animals, Dose-Response Relationship, Drug, Male, Mental Processes, drug effects, Mice, Nitric Oxide Synthase, antagonists & inhibitors, Phencyclidine, pharmacology, Receptors, N-Methyl-D-Aspartate, antagonists & inhibitors, Startle Reaction, drug effects
Ämneskategorier Farmakologi och toxikologi

Sammanfattning

Agmatine, a decarboxylation product of arginine, is thought to be an important neuromodulator in the mammalian brain. It is proposed to exert neuroprotective, anxiolytic and antidepressant effects. The receptor-binding profile of agmatine is complex and includes interaction with alpha(2)-adrenergic and imidazoline I(1) receptors. Furthermore, agmatine is an NMDA-receptor antagonist and inhibits nitric oxide synthase. Prepulse inhibition (PPI) of the acoustic startle response is used as a measure of the pre-attentive information processing. PPI is lowered in schizophrenia and this impairment can be mimicked in experimental animals using the psychotomimetic drug phencyclidine (PCP). The aim of the present study was to investigate the effects of agmatine per se on the PPI response and the effects of agmatine pre-treatment on a PCP-induced disruption of PPI. Agmatine administration (10, 20 and 40 mg/kg) did not change the PPI response or the acoustic startle response. However, pre-treatment with agmatine 20 mg/kg, but not agmatine 40 mg/kg, significantly attenuated a PCP (5 mg/kg)-induced disruption of the PPI response. These results emphasize the potential role of agmatine as a neuromodulator and potential target for novel treatments for brain disorders.

Sidansvarig: Webbredaktion|Sidan uppdaterades: 2012-09-11
Dela:

På Göteborgs universitet använder vi kakor (cookies) för att webbplatsen ska fungera på ett bra sätt för dig. Genom att surfa vidare godkänner du att vi använder kakor.  Vad är kakor?